You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Overall response and disease control rates (ITT population)

From: Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

Response n = 31
Best overall*  
Complete 0
Partial 1 (3.2%)
Stable disease 10 (32.3%)
Progressive disease 19 (61.3%)
Not determinable 1 (3.2%)
Disease control rate 11 (35.5%)
  1. *Summary from site and central review; Calculated as (complete response + partial response + stable disease)/number of patients.